MX9200214A - Producto farmaceutico que comprende granisetron y dexametasona. - Google Patents

Producto farmaceutico que comprende granisetron y dexametasona.

Info

Publication number
MX9200214A
MX9200214A MX9200214A MX9200214A MX9200214A MX 9200214 A MX9200214 A MX 9200214A MX 9200214 A MX9200214 A MX 9200214A MX 9200214 A MX9200214 A MX 9200214A MX 9200214 A MX9200214 A MX 9200214A
Authority
MX
Mexico
Prior art keywords
dexametasone
pharmaceutical product
product including
granisetron
including granisetron
Prior art date
Application number
MX9200214A
Other languages
English (en)
Inventor
Gareth John Sanger
Christopher Stuart Dott
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MX9200214A publication Critical patent/MX9200214A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9200214A 1991-01-19 1992-01-17 Producto farmaceutico que comprende granisetron y dexametasona. MX9200214A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919101221A GB9101221D0 (en) 1991-01-19 1991-01-19 Pharmaceuticals

Publications (1)

Publication Number Publication Date
MX9200214A true MX9200214A (es) 1992-08-01

Family

ID=10688722

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9200214A MX9200214A (es) 1991-01-19 1992-01-17 Producto farmaceutico que comprende granisetron y dexametasona.

Country Status (12)

Country Link
EP (1) EP0567498A1 (es)
JP (1) JP3521143B2 (es)
KR (1) KR930702991A (es)
AU (1) AU658169B2 (es)
CA (1) CA2100777C (es)
GB (1) GB9101221D0 (es)
IE (1) IE920148A1 (es)
MX (1) MX9200214A (es)
NZ (1) NZ241337A (es)
PT (1) PT100033B (es)
WO (1) WO1992012716A1 (es)
ZA (1) ZA92343B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
US20060263421A1 (en) * 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
US20080241231A1 (en) * 2007-02-21 2008-10-02 Victory Pharma, Incorporated Transdermal delivery of dexamethasone and promethazine
JP5537104B2 (ja) * 2009-09-16 2014-07-02 テルモ株式会社 制吐剤
KR101368587B1 (ko) 2010-12-27 2014-03-05 주식회사 삼양바이오팜 오심 또는 구토 방지용 조성물
CN103222977A (zh) * 2013-05-22 2013-07-31 南京工业大学 一种格拉司琼和地塞米松复方经皮控释贴剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650772T2 (de) * 1985-04-27 2003-04-03 F. Hoffmann-La Roche Ag, Basel Derivate von Indazole-3-carboxamide und -3-carboxylsäure
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
PT100033B (pt) 1999-09-30
CA2100777C (en) 2003-08-19
NZ241337A (en) 1994-07-26
JP3521143B2 (ja) 2004-04-19
ZA92343B (en) 1992-12-30
EP0567498A1 (en) 1993-11-03
PT100033A (pt) 1993-02-26
AU658169B2 (en) 1995-04-06
AU1164192A (en) 1992-08-27
KR930702991A (ko) 1993-11-29
JPH06507152A (ja) 1994-08-11
IE920148A1 (en) 1992-07-29
GB9101221D0 (en) 1991-02-27
WO1992012716A1 (en) 1992-08-06
CA2100777A1 (en) 1992-07-20

Similar Documents

Publication Publication Date Title
MX9200798A (es) Producto absorbente.
NL350021I1 (nl) 3-Aryl-4-hydroxy-delta3-dihydrofuranon- en 3-aryl-4-hydroxy-delta3-dihydrothiofenon-derivaten.
FI922958A0 (fi) Farmaceutisk sammansaettning.
FI922316A0 (fi) Farmaceutisk sammansaettning.
FI922252A0 (fi) Farmaceutisk sammansaettning.
NO923127L (no) Farmasoeytisk kombinasjonsformulering
DK0616523T3 (da) Lægemidler
FI930737A7 (fi) Asialoglykoproteiiniin sidottu lääkeaine
FI935314L (fi) Farmaceutisk baerande
DE69206378D1 (de) Patientenliegetische.
FI940072L (fi) Pyrrolidiinijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
ITRM920237A1 (it) Perfezionato impiego di medicinali broncodilatatori b2.
FI924456L (fi) Laekemedel
MX9102701A (es) Derivados de 2-acilamido de 3,4-dihidro-3-oxo-quinoxalina que tienen actividad farmaceutica.
DZ1559A1 (fr) Compositions pharmaceutiques.
MX9201848A (es) Antiserotoninas, procedimiento para su preparacion y medicamentos que las contienen.
FI941958A7 (fi) 2-heterosyklinenetyyliamiinijohdannaiset ja niiden käyttö lääkkeinä
FI923458A7 (fi) 4,5-sykloalkano-3-bentsatsepin-7-olijohdannaiset ja niiden käyttö
FI923371A0 (fi) En farmaceutisk formulation.
FI945672L (fi) Elastosoleja, niiden valmistaminen käyttöä varten sekä niistä tehtyjä tuotteita
FI921785A7 (fi) Farmaceutisk foerening
FI921786A7 (fi) Farmaceutisk foerening
FI942803A7 (fi) Ipsapironi-lääkevalmiste
MX9205375A (es) Nuevos derivados de bencilamina y el medicamento que los contienen.
ATE93197T1 (de) Abschliessbare dose.